Please provide your email address to receive an email when new articles are posted on . In this video perspective, Benjamin Segal, MD, discusses the Kenneth P. Johnson Memorial Lecture he delivered at ...
The treatment of multiple sclerosis (MS) has evolved remarkably over the past 25 years. This progress has been enabled by advances in research, drug development and active engagement of the scientific ...
Neurofilament light chain is a promising noninvasive biomarker for multiple sclerosis (MS), but lacks disease specificity due to other neurological causes. Apolipoprotein levels are negatively ...
DUBAI, UAE — Benign multiple sclerosis (BMS) remains a controversial condition; whether it exists at all, and if it does, how to predict which patients will have a benign course is an open question. A ...
A new analysis may give clinicians a more in-depth understanding of an individual patient’s multiple sclerosis (MS) disease course. Structural and functional measures obtained by MRI can help ...
A 62 year-old woman with multiple sclerosis was admitted to the hospital for confusion. She had moderate cognitive dysfunction. All four limbs were spastic and weak, and she was incontinent of urine.
A 32 year-old man with multiple sclerosis presented with double vision, slurred speech and difficulty walking. Examination showed bilateral internuclear ophthalmoplegias, limb ataxia, and scanning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results